Back
NeoGenomics Vs. Ensysce Biosciences Industry Stock Comparison
Sell
35
NEO
NeoGenomics
Last Price:
15.18
Seasonality Move:
-5.43%
Sell
22
ENSC
Ensysce Biosciences
Last Price:
0.81
Seasonality Move:
-19.56%
Sell
35
NeoGenomics (NEO)
is a Sell
Is NeoGenomics a Buy, Sell or Hold?
- The current NeoGenomics [NEO] share price is $15.20. The Score for NEO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- NEO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Ensysce Biosciences (ENSC)
is a Sell
Is Ensysce Biosciences a Buy, Sell or Hold?
- The current Ensysce Biosciences [ENSC] share price is $0.80. The Score for ENSC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ENSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $15.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEO is experiencing selling pressure, which indicates risk of future bearish movement.
ENSC Stock Price Chart
What is Ensysce Biosciences's stock price today?
-
The Ensysce Biosciences share price today is $0.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENSC is experiencing selling pressure, which indicates risk of future bearish movement.
NEO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 48.34 | Sell |
Chaikin Money Flow: | -470953 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.98 - 16.12) | Sell |
Bollinger Bands (100): | (14.76 - 18.34) | Sell |
ENSC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 42.64 | Sell |
Chaikin Money Flow: | -100746 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.76 - 0.88) | Sell |
Bollinger Bands (100): | (0.81 - 1.25) | Sell |
NEO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.08 | Buy |
20-day SMA: | 15.38 | Sell |
50-day SMA: | 15.35 | Sell |
200-day SMA: | 15.62 | Sell |
8-day EMA: | 15.14 | Buy |
20-day EMA: | 15.27 | Sell |
50-day EMA: | 15.56 | Sell |
200-day EMA: | 15.61 | Sell |
ENSC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.81 | Sell |
20-day SMA: | 0.8 | Sell |
50-day SMA: | 1.03 | Sell |
200-day SMA: | 1.4 | Sell |
8-day EMA: | 0.8 | Sell |
20-day EMA: | 0.83 | Sell |
50-day EMA: | 0.95 | Sell |
200-day EMA: | 10.95 | Sell |
NeoGenomics Earnings Growth & NEO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.20 per share, and an increase next year of $0.11 per share.
Ensysce Biosciences Earnings Growth & ENSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.03 per share, an increase next quarter of $0.17 per share, an increase this year of $17.95 per share, and an increase next year of $1.37 per share.
NeoGenomics Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ensysce Biosciences Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |